February 6, 2026
Research led by Weill Cornell Medicine and the New York Genome Center has illuminated how bladder cancer originates and progresses. Dr. Olivier Elemento collaborated with Dr. Bishoy Faltas on this investigation into the genetic mechanisms underlying the disease.
The study used advanced genomic techniques to uncover key mutations and DNA structural changes that drive bladder cancer development, offering new insights that could lead to improved diagnostic and therapeutic strategies.
Read the full article at news.weill.cornell.edu